NCT00472641View on ClinicalTrials.gov

Geodon in Weight Loss Study for Bipolar Disorders

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Bipolar Disorder
Interventions
DRUG

Ziprasidone/Geodon

Ziprasidone/Geodon

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Stanford University

OTHER

NCT00472641 - Geodon in Weight Loss Study for Bipolar Disorders | Biotech Hunter | Biotech Hunter